Search - tctmd.com

Displaying 221 - 240 of 840

Sort: Relevancy | Date

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

October 06, 2023

Cardiology Society Leaders Expand on Vision for New Medical Board

News Daily News

Cardiology Society Leaders Expand on Vision for New Medical Board

October 05, 2023

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

September 28, 2023

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

September 18, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

News Daily News

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

September 07, 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

August 31, 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

August 30, 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

August 25, 2023

TCTMD’s Michael O’Riordan Wins Digital Health Award

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

August 22, 2023

High Troponin Signals Increased Mortality Risk in Broad Hospital Cohort

News Daily News

High Troponin Signals Increased Mortality Risk in Broad Hospital Cohort

August 10, 2023

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

August 08, 2023

August 2023 News Roundup

News Opinion CV Team Dispatch

August 2023 News Roundup

August 01, 2023

Women and Minorities Underrepresented in Heart Valve Trials

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

July 27, 2023

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

News Daily News

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

July 18, 2023

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

News Daily News

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

July 17, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.